
"Know where your valuable shipments are. Analyze what condition they are in. Take action in real time."
Founded
2015
11 years
Employees
201-500
Annual Revenue
Not Disclosed
(2026)
Products
1
Tive Inc. is a supply chain visibility company founded in 2015, headquartered in Boston, Massachusetts. The company develops sensor-driven tracking devices and a cloud-based platform for real-time shipment monitoring across temperature, humidity, shock, light, and location.
Tive serves 950+ global shippers and logistics providers with 2M+ trackers deployed and 4.5M+ real-time alerts delivered. The platform monitors food & beverage, life sciences & pharmaceuticals, high-value goods, and transportation & logistics shipments.
In September 2025, Tive partnered with AstraZeneca to provide temperature visibility for FluMist® Home at-home flu vaccine service. Named customers include DSV, GEODIS, CH Robinson, YSDS, Optimize Courier, and Biocair.
The company has raised $120M in total funding across 11 rounds from 21 investors. Most recent: $40M Series C (December 2024) led by World Innovation Lab and Sageview Capital. Previous Series B ($54M, April 2022) was led by AXA Venture Partners.
Tive serves life sciences and pharmaceutical industries with GxP-compliant cold chain monitoring solutions. The Tive Solo Pro tracker was specifically designed for pharmaceutical and life sciences shipments, released April 2025.
Named pharmaceutical customers: AstraZeneca (FluMist® Home partnership September 2025), YSDS (Swedish life sciences logistics with 80,000+ annual shipments), Optimize Courier (BioPharma and expedited time-critical shipments), Biocair (cell and gene therapy specialist).
Compliance certifications: FDA 21 CFR Part 11, EU Annex 11, GAMP 5, SOC 2 Type 2, ISO/IEC 27001, ISO 9001:2015. All trackers include 3-Point NIST-traceable calibration certificates and ISO 17025-certified probes.
Supports pharmaceutical temperature profiles from -200°C (cryogenic) to 50°C with ±0.5°C accuracy.
Industries Served
VC-backed company with $120M total funding across 11 rounds from 21 investors.
Most recent: $40M Series C (December 2024) led by World Innovation Lab and Sageview Capital.
Previous rounds: $54M Series B (April 2022) led by AXA Venture Partners with participation from Sorenson Capital, Qualcomm Ventures, Fifth Wall, SJF Ventures, Floating Point Ventures, RRE Ventures, Two Sigma Ventures, NextView Ventures, Hyperplane Ventures, Broom Ventures, and Supply Chain Ventures.
Company reported 300%+ revenue growth in 2021 and acquired 200+ new customers that year.
Browse all software products offered by Tive Inc..
**Real-Time Trackers:** - Tive Solo Pro: Pharma-grade tracker with 2.66-inch display, -200°C to 50°C, ±0.5°C accuracy, ISO 17025 calibration - Tive Solo 5G: Multi-sensor tracker for temperature, humidity, shock, light; Lithium and Non-Lithium models - Tive Solo Lite: Basic tracking with temperature and location
**Passive & Security:** - Tive Tag: Passive temperature loggers without active connectivity - Tive Seal: Security solution for tamper detection
**Platform & Services:** - Tive Platform: Cloud-based dashboard with real-time monitoring, alerts, and reporting - 24/7 Live Monitoring: Active intervention service when shipment issues occur
2M+ trackers deployed; 4.5M+ real-time alerts delivered.
Technology: Global cellular connectivity across 400+ networks, GPS (10m accuracy), WiFi positioning. EASA and FAA flight-safe certification (EUROCAE ED-14, RTCA/DO-160).
Strategic partnership: AstraZeneca (September 2025) for FluMist® Home temperature visibility.
Logistics partners: DSV, GEODIS, CH Robinson.
TMS integration available via API.
24/7 Live Monitoring team provides active intervention when shipment issues occur. Users report responsive customer support: "Great team that allows us to work quickly and easily. Very responsive to issues."
Cloud-based platform accessible via web dashboard. TMS integration support available.
FreightWaves FreightTech 25 #17 ranking. SelectHub #4 in Supply Chain Visibility Software. Four industry awards in H1 2025 for innovation, customer impact, and sustainability.
90% User Satisfaction Rating based on 96 reviews. AstraZeneca partnership (September 2025) demonstrates enterprise pharmaceutical adoption.
SOC 2 Type 2, ISO/IEC 27001, ISO 9001:2015 certified. FDA 21 CFR Part 11 and EU Annex 11 compliant.
950+ global shippers and logistics providers. 2M+ trackers deployed. 4.5M+ real-time alerts delivered.
Listed on G2 and Capterra in Supply Chain Visibility category.
Active investment with $40M Series C in December 2024 demonstrating continued growth.
Headquarters
Boston, Massachusetts, United States
Founded
2015 (11 years in business)
Company Size
201-500 employees
Type
Private
Owned by Not applicable - independent company
Annual Revenue
Not Disclosed (2026)
Office Locations